For example, anti-TNF−alpha antibodies have been shown to decrease pro-inflammatory (45) and increase anti-inflammatory intestinal macrophage subpopulations in IBD, potentially contributing to disease resolution (46, 47). The gene discussed is TNF; the disease is irritable bowel syndrome.